BREMELANOTIDE PT-141

Benefits of Bremelanotide PT-141

• Treats premature ejaculation, impotence and erectile dysfunction in males.
• Useful in treating women who suffer from sexual arousal disorder
• Increased sexual desire (libido) through its stimulation of the central nervous system
• It does not target the vascular system. Instead, it acts on the nervous system via activation of neurons in the hypothalamus to increase sexual desire.

What is Bremelanotide PT-141?

Bremelanotide PT-141 is a peptide that was developed out of the peptide hormone Melanotan II, with its function specific to the treatment of sexual dysfunction experienced by both men and women. In clinical studies, it was discovered that an unexpected side effect in 9 out of 10 male subjects taking using Melanotan II, was a spontaneous erection. Further studies went on to prove its effectiveness in increasing sexual desire through the nervous system rather than the vascular system. An aphrodisiac of revolutionary proportion, it has been made available to administer through oral strip technology. It has thus far endured over 20 years of basic and clinical research whereby male and female sexual responses have led doctors to assess a multitude of pharmacological options for Bremelanotide PT-141 in treating male erectile dysfunction (ED) and female sexual arousal and orgasmic disorders.

Molecular Weight: 1025.2

Molecular Formula: C50H68N14O10

Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH

Bremelanotide PT-141 – How it works

Studies reveal that PT-141 does not act on the vascular system. Bremelanotide PT-141 mechanism of action is via the activation of melanocortin receptors MC3-R and MC4-R in the brain. The chemical interaction allows PT-141 to regulate brain transmissions related to sexual function and mood. It also governs those specific to inflammation and blood flow restriction. Because of this, scientists hypothesise the potential for PT-141 to manage the onset of hemorrhagic shock. Other potential treatment objectives may be in the reduction of damage occurring within blood vessels and surrounding tissue, alongside inflammation caused by chronic disease and/or irritants.

The discovery of Bremelanotide PT-141

Developed from the Melanotan 2 Peptide, after clinical studies revealed a peculiar side effect from the sunless tanning agent. The side effect of spontaneous male erections paved the way for the development of PT-141 in the treatment of sexual dysfunction.

Side effects of Bremelanotide PT-141

There is the potential for experiencing side effects. However, most of these are minimised by following the dosage instructions advised by our peptide doctor.

Dizzy Spells
Hot flashes
Facial and skin flushing
Nausea or Vomiting
Post-nasal drip
Post-injection discharge
High blood pressure
Altered taste sensation
Hypertension
Headache
Increased Sweating